undefined
Posts
undefined
Followers
User since undefined NaN
Can a Genetic Variant Affect the Efficacy of Abiraterone?
By The ASCO Post Staff,
2026-01-16Data from a major clinical trial from the Alliance for Clinical Trials in Oncology have uncovered a genetic factor that may inform how to optimize the dosing of abiraterone, a widely used hormonal treatment for advanced prostate cancer. Published by Norton et al in Clinical and Translational Science, this secondary analysis of Alliance A032201 could lead to more personalized treatments for patients.